Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
SUBSCRIBE FOR FREE
Twitter
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine > News > Generation X will experience higher rates of cancer than earlier generations
  • News

Generation X will experience higher rates of cancer than earlier generations

  • 27 June 2024
  • Janet Fricker
Generation X will experience higher rates of cancer than earlier generations
Total
0
Shares
0
0
0
0
0

At age 60 members of Generation X, defined as people born between 1965 and 1980, are projected to have higher rates of cancer than Baby Boomers, born between 1946 and 1964. The US modelling study, published online in JAMA OpenNetwork, 10 June, revealed that, among Generation X men, declines in lung, liver, and gallbladder cancers and non-Hodgkin lymphoma have been overtaken by gains in thyroid, kidney, rectal, colon, and prostate cancers, and leukaemia. Among Generation X women, statistically significant declines in lung and cervical cancers have been overtaken by significant increases in thyroid, kidney, rectal, corpus uteri, colon, pancreatic, and ovarian cancer, and non-Hodgkin lymphoma, and leukaemia.

“The models in this cohort study suggest that Generation X is experiencing larger per-capita increases in the incidence of leading cancers combined than any prior generation from 1908 through 1964,” write the authors Philip Rosenberg and Adalberto Miranda-Filho, from the National Cancer Institute in Bethesda, Maryland. “If the Millennials’ cancer experience follows the estimated trajectory of their proxy parents, cancer incidence in the U.S. could remain unacceptably high for decades to come.”

In the study Rosenberg and Miranda-Filho set out to address the question of whether cancer incidence in successive social generations in the US was slowing or growing. First, the investigators analysed data on people with invasive cancer diagnosed between the ages of 35 and 84 years, recorded in the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program’s 13-registry database.

Then, they used the data to calculate cancer rates for several defined generations using a tool called the age-period-cohort model that captures the net impact of three factors: age effects (representing the underlying biology of cancer, such as the role of ageing), period effects (temporal trends relating to specific events such as introduction of new carcinogens or changes in diagnostic criteria), and birth cohort effects (related to collective lifestyle changes or environmental exposures experienced at the same life stage). The way cancer rates changed with time was expressed using fitted cohort pattern incidence rates that calculate the rates of different cancers per 100,000 person-years for different birth cohorts at the age of 60.

In total, the investigators analysed 3.8 million cases of incident cancer occurring over 521 million person-years.

Results for men showed that the fitted cohort pattern incidence rate ratios in Generation X vs Baby Boomers were significantly increased for thyroid (2.16; 95%CI 1.87–2.50), kidney (2.14; 95%CI 1.86–2.46), rectal (1.80; 95%CI 1.52–2.21), colon (1.60; 95%CI 1.32–1.94), and prostate (1.25; 95%CI 1.03–1.52) cancers, and leukaemia (1.34; 95%CI 1.08–1.66).

Results for women showed that the fitted cohort pattern incidence rate ratios in Generation X vs Baby Boomers were significantly increased for thyroid (2.76; 95%CI 2.41–3.15), kidney (1.99; 95%CI 1.70–2.32), rectal (1.84; 95%CI 1.52–2.22) , corpus uterine (1.75; 95%CI 1.40–2.18), colon (1.56; 95%CI 1.27–1.92), and pancreatic (1.39; 95%CI 1.07–1.80) cancers, non-Hodgkin lymphoma (1.40; 95%CI 1.08–1.82), and leukaemia (1.27; 95%CI 1.03–1.58).

Among men, fitted cohort pattern incidence rate ratios in Generation X vs Baby Boomers were significantly lower for lung (0.51; 95%CI 0.43–0.60), liver (0.76; 95%CI 0.63–0.91), and gallbladder (0.85; 95%CI 0.72–1.00) cancers, and non-Hodgkin lymphoma (0.75; 95%CI 0.61–0.93).

Among women, fitted cohort pattern incidence rate ratios in Generation X vs Baby Boomers were significantly lower for lung (0.60; 95%CI 0.50–0.72) and cervical (0.71; 95%CI 0.57–0.89) cancers.

The researchers also found rates of cancers differed by race, with Hispanic women shown to have the greatest increase compared with their parents (34.9%).

“The substantial increases we identified in Generation X vs both Baby Boomers and their proxy parents surprised us,” write the authors. “Numerous preventable causes of cancer have been identified. Cancer control initiatives have led to substantial declines in tobacco consumption. Screening is well accepted for precancerous lesions of the colon, rectum, cervix, uterus, and breast. However, other suspected carcinogenic exposures are increasing.” Some portion of these increases can be attributed to rising obesity rates and increasingly sedentary lifestyles, they add.

“Our results beg the question of what the cancer experience may be like among the 72 million Millennials (1981–1996) when they enter their 40s, 50s and 60s,” write the authors.

Preventive actions to diminish cancer risks, including reducing tobacco and alcohol use, increasing physical activity, improving dietary habits, and promoting breast feeding, are not being adopted by all sectors of the population. Access to healthy lifestyles, write the authors, is hampered by income inequality, deficits in the built environment, and other factors that make it difficult for everyone to eat healthily and stay active.

“Taken together, these findings indicate that for many people in the US, a healthy lifestyle remains, to various degrees, an unattainable privilege rather than a fundamental right. The extent to which lifestyle disparities explain rising generational cancer rates in our data and falling life expectancies in other studies is unclear and in our view, merits further study,” conclude the authors.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • Baby boomers
  • cancer incidence
  • fitted cohort pattern incidence
  • Generation X
  • generational trends
  • health inequalities
  • Millennials
Janet Fricker

Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.

Previous Article
  • Articles
  • Practice Points

If the risk is very low, should we still call it ‘cancer’?

  • 26 June 2024
  • Simon Crompton
View Post
Next Article
  • News

Neoadjuvant immunotherapy delivers unprecedented pathological response in mismatch repair deficient non-metastatic colon cancers

  • 28 June 2024
  • Janet Fricker
View Post
You May Also Like
View Post
  • News

Key link identified in mechanism promoting lung metastases from breast cancer

  • Janet Fricker
  • 17 February 2025
View Post
  • News

OncoDaily Acquires CancerWorld: A New Era in Oncology Media

  • Christopher Greenberg
  • 22 January 2025
View Post
  • News

Second-generation BTK inhibitor shows promise as fixed-duration therapy in CLL

  • Janet Fricker
  • 18 December 2024
View Post
  • News

New evidence can help inform decisions on managing early-onset breast cancer linked to BRCA mutations

  • Janet Fricker
  • 18 December 2024
View Post
  • News

Gut microbiota influence effectiveness of tamoxifen in breast cancer

  • Janet Fricker
  • 6 December 2024
View Post
  • News

Radiotherapy prior to immunotherapy is the best treatment sequence for melanoma related brain metastases

  • Janet Fricker
  • 6 December 2024
View Post
  • News

Study helps solve the puzzle of checkpoint inhibitor myocarditis

  • Janet Fricker
  • 22 November 2024
View Post
  • News

Smoking cessation fundamental to first-line cancer care

  • Janet Fricker
  • 21 November 2024
search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Key link identified in mechanism promoting lung metastases from breast cancer
    • 17 February 2025
  • OncoDaily Acquires CancerWorld: A New Era in Oncology Media
    • 22 January 2025
  • Second-generation BTK inhibitor shows promise as fixed-duration therapy in CLL
    • 18 December 2024
  • New evidence can help inform decisions on managing early-onset breast cancer linked to BRCA mutations
    • 18 December 2024
  • Gut microbiota influence effectiveness of tamoxifen in breast cancer
    • 6 December 2024
Article
  • China’s integrated cancer care guidelines ‘reflect self-confidence’ in the field of oncology
    • 15 February 2025
  • Europe’s cancer agenda: how we keep it a priority in changing times
    • 20 December 2024
  • Humour: an essential tool in cancer care and communication
    • 18 December 2024
Social

Would you follow us ?

Contents
  • Stella Kyriakides: using her voice to improve health in Europe
    • 22 November 2024
  • Bulgarian oncologist Assia Konsoulova
    Assia Konsoulova: improving Bulgaria’s cancer system one oasis at a time
    • 8 November 2024
  • Mohit Singh and his mother Amrita: they are the protagonists of a long and ultimately unsuccessful journey across India in search of cures for her cancer
    ‘I feel guilty sometimes’: a young carer reflects on three years of a losing battle to save his mum
    • 24 October 2024
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.